Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 12;7(11):ofaa518.
doi: 10.1093/ofid/ofaa518. eCollection 2020 Nov.

Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series

Jaclyn A Cusumano  1   2 , Amy C Dupper  3   4 , Yesha Malik  3   4 , Elizabeth M Gavioli  2   5 , Jaspreet Banga  3 , Ana Berbel Caban  4 , Devika Nadkarni  3 , Ajay Obla  6 , Chirag V Vasa  1 , Dana Mazo  1   3   4 , Deena R Altman  4   6
Affiliations

Staphylococcus aureus Bacteremia in Patients Infected With COVID-19: A Case Series

Jaclyn A Cusumano et al. Open Forum Infect Dis. .

Abstract

Background: Previous viral pandemics have shown that secondary bacterial infections result in higher morbidity and mortality, with Staphylococcus aureus being the primary causative pathogen. The impact of secondary S. aureus bacteremia on mortality in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unknown.

Methods: This was a retrospective observational case series of patients with coronavirus disease 2019 (COVID-19) who developed secondary S. aureus bacteremia across 2 New York City hospitals. The primary end point was to describe 14-day and 30-day hospital mortality rates of patients with COVID-19 and S. aureus bacteremia. Secondary end points included predictors of 14-day and 30-day hospital mortality in patients with COVID-19 and S. aureus bacteremia.

Results: A total of 42 patients hospitalized for COVID-19 with secondary S. aureus bacteremia were identified. Of these patients, 23 (54.8%) and 28 (66.7%) died at 14 days and 30 days, respectively, from their first positive blood culture. Multivariate analysis identified hospital-onset bacteremia (≥4 days from date of admission) and age as significant predictors of 14-day hospital mortality and Pitt bacteremia score as a significant predictor of 30-day hospital mortality (odds ratio [OR], 11.9; 95% CI, 2.03-114.7; P = .01; OR, 1.10; 95% CI, 1.03-1.20; P = .02; and OR, 1.56; 95% CI, 1.19-2.18; P = .003, respectively).

Conclusions: Bacteremia with S. aureus is associated with high mortality rates in patients hospitalized with COVID-19. Further investigation is warranted to understand the impact of COVID-19 and secondary S. aureus bacteremia.

Keywords: COVID-19; SARS-CoV-2; Staphylococcus aureus; bacteremia.

PubMed Disclaimer

References

    1. Guan WJ, Ni ZY, Hu Y, et al. . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708–20. - PMC - PubMed
    1. Redd WD, Zhou JC, Hathorn KE, et al. . Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology 2020; 159:765–7.e2. - PMC - PubMed
    1. Klok FA, Kruip MJHA, van der Meer NJM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020; 191:145–7. - PMC - PubMed
    1. Richardson S, Hirsch JS, Narasimhan M, et al. ; the Northwell COVID-19 Research Consortium Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020; 323:2052–9. - PMC - PubMed
    1. Sepulveda J, Westblade LF, Whittier S, et al. . Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol. 2020; 58:e00875-20. - PMC - PubMed